Iambic is creating a future where anyone can comfortably walk in shoes with perfect form, fit, and function. By merging science, data, AI, and supply chain innovation, we are building a new paradigm for how shoes are designed, made, and worn. Iambic’s patent-pending technological innovations and National Science Foundation-supported research will unlock human potential by transforming how people walk, everyday and everywhere, one step at a time.
Learn more at iambic.co.
Learn more at iambic.co.
Location: United States, New York
Employees: 1-10
Total raised: $256K
Investors 1
| Date | Name | Website |
| - | Awesome Pe... | awesomepeo... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.09.2021 | Grant | $256K | - |
Mentions in press and media 2
| Date | Title | Description |
| 13.10.2023 | Iambic Therapeutics: $100 Million Oversubscribed Series B Funding Raised | Iambic Therapeutics (formerly known as Entos) – a biotechnology company developing novel therapeutics from its unique generative AI discovery platform – recently announced the closing of an oversubscribed $100 million Series B financing co-... |
| 03.10.2023 | Iambic Therapeutics Secures $100M Series B | SAN DIEGO, CA, Iambic Therapeutics (formerly known as Entos) today announced the closing of an oversubscribed $100 million Series B financing. >> Click here for more funding data on Iambic Therapeutics >> To export Iambic Th... |